瓜氨酸化
表位
免疫系统
抗原
抗体
生物
T细胞
化学
分子生物学
免疫学
瓜氨酸
生物化学
氨基酸
精氨酸
作者
Matthew K. McElwee,Thamotharampillai Dileepan,Shawn A. Mahmud,Marc K. Jenkins
摘要
Rheumatoid arthritis occurs most often in people who express HLA-DR molecules containing a five aa “shared epitope” in the β chain. These MHCII molecules preferentially bind citrullinated peptides formed by posttranslational modification of arginine. Citrullinated peptide:HLA-DR complexes may act as arthritis-initiating neo-antigens for CD4+ T cells. Here, we used fluorophore-conjugated HLA-DR tetramers containing citrullinated peptides from human cartilage intermediate layer protein, fibrinogen, vimentin, or enolase 1 to track cognate CD4+ T cells. Immunization of HLA-DR transgenic mice with citrullinated peptides from vimentin or enolase 1 failed to cause any expansion of tetramer-binding cells, whereas immunization with citrullinated peptides from cartilage intermediate layer protein or fibrinogen elicited some expansion. The expanded tetramer-binding populations, however, had lower T helper 1 and higher regulatory T cell frequencies than populations elicited by viral peptides. These results indicate that HLA-DR–bound citrullinated peptides are not neo-antigens and induce varying degrees of immune tolerance that could pose a barrier to rheumatoid arthritis.
科研通智能强力驱动
Strongly Powered by AbleSci AI